Ocuphire Pharma Results slide image

Ocuphire Pharma Results

Diabetic Patients Usually Present with Complex Co-Morbidities Diabetic Patients are Young and Face Life-long Systemic and Ocular Complications DR is the most common cause of vision loss or blindness in working- age adults, usually affecting both eyes DME is a vision threatening complication caused by DR where excess fluid leaks near fovea and triggers swelling of the macula Treating DR leads to control of DME Ocuphire PHARMA Diabetic retinopathy¹ Dyslipidemia² Diabetic neuropathy¹ Patients with DME have an even greater risk of complications than diabetes patients without DME5,6 Stroke¹ K Cardiovascular disease² Diabetic nephropathy¹,2 Oral options have the potential to reach other vascular beds to treat kidney and neuropathic co-morbidities 1. Petrella RJ, et al. J Ophthalmol 2012;159167; 2. International Diabetes Federation, Diabetes Atlas 6th Edition, http://www.idf.org/diabetesatlas; 3. National Diabetes Fact Sheet, 2011 http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf; 4. Rodbard HW, et al. Endocr Pract 2007;13:4-69; 5. Wong TY, et al. JAMA 2002;288:67-74; 6. Nguyen-Khoa B, et al. BMC Ophthalmol 2012;12:11 12
View entire presentation